News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
Weed Week: G-men getting on the hype train
Health & Biotech
How do you get patients to accept cannabis? Treat it like any other medicine
Experts
Money Talks: Cannabis could ‘easily’ be a $200b-plus market
News
Weed Week: Oz gets serious with medical marijuana, new clinics rolling out soon
News
Weed Week: US looks at ways to help cannabis players get banking access
News
Weed week: cannabis is about to get scary in Canada
Health & Biotech
The Pot Seat distilled: The 9 key things we know now about Aussie cannabis
Director Trades
Director Trades: Who was buying and who was selling last week
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
News
Corporate: Zelda director sells stock after board promises not to sell stock
Health & Biotech
Health: Pharmaxis on verge of $14.3m payout after FDA close call on Bronchitol
News
Weed Week: Has pot *really* gone from Pineapple Express to luxury status symbol?
The Pot Seat: Zelda’s Richard Hopkins says registering pot drugs is a luxury
News
Tl;dr? Here are your Budget cliff notes on what’s in store for ASX small caps
News
These are the ASX small caps that might benefit from the Budget
Check-up: What’s happening with the ASX small cap health stocks?
Health & Biotech